Dusseldorf - Delayed Quote EUR

Anavex Life Sciences Corp (12X1.DU)

Compare
8.89
+0.10
+(1.18%)
At close: January 31 at 7:30:09 PM GMT+1
Loading Chart for 12X1.DU
DELL
  • Previous Close 8.78
  • Open 9.10
  • Bid 8.84 x --
  • Ask 9.04 x --
  • Day's Range 8.89 - 9.12
  • 52 Week Range 3.04 - 13.34
  • Volume 0
  • Avg. Volume 16
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 5, 2025 - Feb 10, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 12X1.DU

View More

Performance Overview: 12X1.DU

Trailing total returns as of 1/31/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

12X1.DU
24.82%
S&P 500
2.26%

1-Year Return

12X1.DU
52.52%
S&P 500
22.65%

3-Year Return

12X1.DU
15.37%
S&P 500
36.30%

5-Year Return

12X1.DU
56.44%
S&P 500
83.96%

Compare To: 12X1.DU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 12X1.DU

View More

Valuation Measures

As of 1/31/2025
  • Market Cap

    756.28M

  • Enterprise Value

    629.13M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    6.52

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 12X1.DU

View More